The Latest Breaking News from Matthew Kacsmaryk

The decision comes shortly after an appeals court left numerous restrictions on abortion pill access in place.

WASHINGTON — Attorney General Merrick Garland said the Biden administration will ask the U.S. Supreme Court to protect the availability of a widely used abortion pill after a federal appeals court cleared the way for new restrictions to take effect Friday.

Court upheld part of a Texas judge's ruling halting FDA decision allowing mifepristone to be distributed by mail

A federal appeals court partly granted the Biden administration’s request to put on hold a Texas court ruling overturning FDA approval of the abortion pill, but allowed restrictions that were lifted since 2016 to be reinstated.

At the heart of the latest battle over abortion access is a federal judge’s ruling that cites concern about the mental health of women who choose to end their pregnancies.

Mifepristone will remain on the market, but approved only for use up to seven weeks of pregnancy, versus 10 weeks, and it cannot be prescribed by telehealth or mailed, which were already illegal in Texas.

The Biden administration had asked the higher court to stay a decision from a Texas judge while the appeal plays out.

People are seeking the advance provision of medication before Friday’s deadline, when the drug may become unavailable

An appeals court ruling prevents an outright ban on mifepristone, but the conservative panel has effectively made the drug harder for millions of Americans to obtain

The chiefs of more than 400 pharmaceutical companies signed a scathing letter this week blasting federal Judge Matthew Kacsmaryk’s ruling that the Food and Drug Administration had overstepped its authority in approving the abortion-inducing drug mifepristone. The letter was more than justified and, while harshly worded, accurately recounted Kacsmaryk’s abysmal…

The ruling means mifepristone is still available in the U.S., but with several strict limitations.